ClinicalTrials.Veeva

Menu

Text Messaging to Increase Activity in Midlife (MASTERY)

Mass General Brigham logo

Mass General Brigham

Status and phase

Completed
Phase 1

Conditions

Middle Aged

Treatments

Behavioral: Attentional Control
Behavioral: MASTERY

Study type

Interventional

Funder types

Other

Identifiers

NCT04849052
2021P000881

Details and patient eligibility

About

This is a randomized controlled pilot trial of a text message intervention to promote physical activity in midlife adults (MASTERY), compared to an attention-matched control condition. The MASTERY intervention utilizes two-way text message sessions once-weekly for 12 weeks focusing on performing activities to enhance well being, setting physical activity goals, and learning techniques to reduce midlife-specific stress.

Full description

This is a randomized controlled pilot trial of a multipronged intervention to promote physical activity in midlife adults (MASTERY), compared to an attention-matched control condition. In MASTERY, participants will have interactive, two-way text message 'sessions' (5-10 minutes of two-way text communication with an automated text-message program) once weekly for 12 weeks. The messages will focus on 3 distinct areas in the same order each week: (1) well-being-based skills and assigned activities, customized for midlife adults, (2) physical activity content focused on setting and reaching weekly activity goals, and (3) specific skills to manage midlife-related stressors that act as barriers to activity. The primary outcome is objectively measured moderate to vigorous physical activity (MVPA). Secondary outcomes include feasibility and acceptability and other activity-related, psychological, and functional outcomes at 12 weeks.

Enrollment

116 patients

Sex

All

Ages

45 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Midlife status (age 45-64 at enrollment).
  2. Low baseline physical activity (≤150 minutes/week of MVPA]) as initially self-reported via the well-validated IPAQ and then confirmed via accelerometer after 7 days of wear.

Exclusion criteria

  1. Existing coronary artery disease (CAD; diagnosed via cardiac catheterization using standard coronary artery stenosis definitions or prior ACS).
  2. An unrelated condition limiting physical activity (e.g., ambulation with a cane or walker, recent or planned surgery, or other condition such that ability to increase moderate to physical activity would be limited).
  3. Participation in any other programs focused on cardiac prevention or well-being (e.g., cardiac rehabilitation).
  4. A cognitive disturbance precluding participation or informed consent, assessed using a six-item screen7 designed to assess suitability for research participation.
  5. Inability to speak/write fluently in English.
  6. No access to a text message-capable phone.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

116 participants in 2 patient groups

MASTERY Intervention
Experimental group
Description:
Participants will complete a positive psychology activity, work towards a physical activity goal, and use a stress reduction technique, then will complete weekly text message sessions. In the first six weeks, participants will review the activities they performed the prior week, be introduced to new material, choose activities to perform that week, and set a new physical activity goal during the text message sessions. In the final 6 weeks, participants will review progress towards prior goals, set new physical activity goals, and choose positive psychology and stress reduction skills to use that week. Finally, over the course of the program participants will complete three brief calls with a study trainer to discuss progress.
Treatment:
Behavioral: MASTERY
Attentional control
Active Comparator group
Description:
Participants will receive the same physical activity component noted in MASTERY along with added messages providing education and guidance about physical activity, from our past work. Control participants will not receive PP or midlife-related content.
Treatment:
Behavioral: Attentional Control

Trial contacts and locations

1

Loading...

Central trial contact

Christopher M Celano, MD; Jeff C Huffman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems